SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-049722
Filing Date
2023-09-18
Accepted
2023-09-18 15:54:48
Documents
2
Period of Report
2023-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15590
2 POA DOCUMENT poa.txt EX-24 3572
  Complete submission text file 0001209191-23-049722.txt   20565
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY SAN FRANCISCO CA 94083
Business Address
SCANGOS GEORGE A (Reporting) CIK: 0001202102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 231261120

Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)